⌘K
Loading ticker…
As of 2026-08-24, Black Diamond Therapeutics, Inc. Common Stock (BDTX) has a 3-month relative strength percentile of 37 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 43. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.3%, relative volume 0.52×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
BDTX is held by 2 ETFs as of May 2026. Top owner: AVSC at 0.01% weight, $164K notional.
Held by 5 ETFs · $904K across latest filings · largest weight 0.15% (SQLV).
Top 2 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVSC | 0.01% | $164K | — |
| AVUVAvantis U.S. Small Cap Value ETF | 0.00% | $28K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BDTX Jan avg: 32.05% median: 29.54% win: 100% σ: 27.00% n: 4 2022-04-12 → 2026-07-31 | BDTX Feb avg: -7.78% median: -12.04% win: 25% σ: 32.34% n: 4 2022-04-12 → 2026-07-31 | BDTX Mar avg: -7.83% median: -7.61% win: 25% σ: 13.11% n: 4 2022-04-12 → 2026-07-31 | BDTX Apr avg: -1.57% median: 9.68% win: 60% σ: 23.03% n: 5 2022-04-12 → 2026-07-31 | BDTX May avg: -0.28% median: -14.18% win: 40% σ: 28.11% n: 5 2022-04-12 → 2026-07-31 | BDTX Jun avg: 42.12% median: 12.73% win: 60% σ: 75.93% n: 5 2022-04-12 → 2026-07-31 | BDTX Jul avg: 9.09% median: 7.26% win: 60% σ: 27.96% n: 5 2022-04-12 → 2026-07-31 | BDTX Aug avg: -3.74% median: -4.35% win: 50% σ: 6.51% n: 4 2022-04-12 → 2026-07-31 (current) | BDTX Sep avg: -13.18% median: -21.76% win: 25% σ: 36.47% n: 4 2022-04-12 → 2026-07-31 | BDTX Oct avg: -8.18% median: -16.19% win: 50% σ: 34.84% n: 4 2022-04-12 → 2026-07-31 | BDTX Nov avg: 2.81% median: -2.29% win: 25% σ: 14.77% n: 4 2022-04-12 → 2026-07-31 | BDTX Dec avg: -12.56% median: -16.97% win: 25% σ: 23.68% n: 4 2022-04-12 → 2026-07-31 |